Fifth Third Bancorp
PBYI icon

Fifth Third Bancorp’s Puma Biotechnology PBYI Stock Holding History

Fifth Third Bancorp’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65 Hold
8
– – ﹤0.01% 4314
2026
Q1 		$51 Buy
+8
New +$52 ﹤0.01% 4278
2016
Q1 		– Sell
-139
Closed -$11K – 2588
2015
Q4 		$11K Sell
139
-1,104
-89% -$86.7K ﹤0.01% 1918
2015
Q3 		$94K Buy
1,243
+369
+42% +$34.9K ﹤0.01% 1171
2015
Q2 		$102K Sell
874
-19
-2% -$3.44K ﹤0.01% 1188
2015
Q1 		$211K Buy
893
+647
+263% +$138K ﹤0.01% 970
2014
Q4 		$47K Sell
246
-14
-5% -$3.11K ﹤0.01% 1418
2014
Q3 		$62K Sell
260
-622
-71% -$128K ﹤0.01% 1322
2014
Q2 		$58K Sell
882
-102
-10% -$7.25K ﹤0.01% 1368
2014
Q1 		$102K Buy
984
+217
+28% +$25.5K ﹤0.01% 1164
2013
Q4 		$79K Buy
767
+6
+0.8% +$352 ﹤0.01% 1148
2013
Q3 		$41K Sell
761
-4,079
-84% -$220K ﹤0.01% 1392
2013
Q2 		$215K Buy
+4,840
New +$171K ﹤0.01% 877

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fifth Third Bancorp's PBYI Position: Q2 2026 in Review

Fifth Third Bancorp held its Puma Biotechnology (PBYI) position steady in Q2 2026 at 8 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #4314.

Fifth Third Bancorp first reported a position in PBYI in Q2 2013 and has held it in 13 quarters since. The position peaked at $215K in Q2 2013. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Fifth Third Bancorp held 8 shares of Puma Biotechnology worth $65 as of Q2 2026.
  • Fifth Third Bancorp left its Puma Biotechnology share count unchanged in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4314 holding.
  • Fifth Third Bancorp first reported a position in Puma Biotechnology in Q2 2013 and has held it in 13 quarters since.
  • Fifth Third Bancorp's Puma Biotechnology position peaked at $215K in Q2 2013.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.